These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

344 related items for PubMed ID: 11906173

  • 1. Attenuation of transforming growth factor beta-induced growth inhibition in human hepatocellular carcinoma cell lines by cyclin D1 overexpression.
    Jong HS, Lee HS, Kim TY, Im YH, Park JW, Kim NK, Bang YJ.
    Biochem Biophys Res Commun; 2002 Mar 29; 292(2):383-9. PubMed ID: 11906173
    [Abstract] [Full Text] [Related]

  • 2. Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells.
    Guo Y, Kyprianou N.
    Cell Growth Differ; 1998 Feb 29; 9(2):185-93. PubMed ID: 9486855
    [Abstract] [Full Text] [Related]

  • 3. Involvement of interferon regulatory factor 1 and S100C/A11 in growth inhibition by transforming growth factor beta 1 in human hepatocellular carcinoma cells.
    Miyazaki M, Sakaguchi M, Akiyama I, Sakaguchi Y, Nagamori S, Huh NH.
    Cancer Res; 2004 Jun 15; 64(12):4155-61. PubMed ID: 15205326
    [Abstract] [Full Text] [Related]

  • 4. Growth inhibition of human hepatoma cells by acyclic retinoid is associated with induction of p21(CIP1) and inhibition of expression of cyclin D1.
    Suzui M, Masuda M, Lim JT, Albanese C, Pestell RG, Weinstein IB.
    Cancer Res; 2002 Jul 15; 62(14):3997-4006. PubMed ID: 12124333
    [Abstract] [Full Text] [Related]

  • 5. TGF-beta1-induced cell growth arrest and partial differentiation is related to the suppression of Id1 in human hepatoma cells.
    Damdinsuren B, Nagano H, Kondo M, Natsag J, Hanada H, Nakamura M, Wada H, Kato H, Marubashi S, Miyamoto A, Takeda Y, Umeshita K, Dono K, Monden M.
    Oncol Rep; 2006 Feb 15; 15(2):401-8. PubMed ID: 16391861
    [Abstract] [Full Text] [Related]

  • 6. Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma.
    Zhang YJ, Jiang W, Chen CJ, Lee CS, Kahn SM, Santella RM, Weinstein IB.
    Biochem Biophys Res Commun; 1993 Oct 29; 196(2):1010-6. PubMed ID: 8240318
    [Abstract] [Full Text] [Related]

  • 7. Transforming growth factor beta 1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells.
    Elbendary A, Berchuck A, Davis P, Havrilesky L, Bast RC, Iglehart JD, Marks JR.
    Cell Growth Differ; 1994 Dec 29; 5(12):1301-7. PubMed ID: 7696178
    [Abstract] [Full Text] [Related]

  • 8. Distortion of autocrine transforming growth factor beta signal accelerates malignant potential by enhancing cell growth as well as PAI-1 and VEGF production in human hepatocellular carcinoma cells.
    Sugano Y, Matsuzaki K, Tahashi Y, Furukawa F, Mori S, Yamagata H, Yoshida K, Matsushita M, Nishizawa M, Fujisawa J, Inoue K.
    Oncogene; 2003 Apr 17; 22(15):2309-21. PubMed ID: 12700666
    [Abstract] [Full Text] [Related]

  • 9. Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation.
    Ozaki I, Zhang H, Mizuta T, Ide Y, Eguchi Y, Yasutake T, Sakamaki T, Pestell RG, Yamamoto K.
    Clin Cancer Res; 2007 Apr 01; 13(7):2236-45. PubMed ID: 17404108
    [Abstract] [Full Text] [Related]

  • 10. Transforming growth factor beta 1 (TGF beta 1) is an autocrine positive regulator of colon carcinoma U9 cells in vivo as shown by transfection of a TGF beta 1 antisense expression plasmid.
    Huang F, Newman E, Theodorescu D, Kerbel RS, Friedman E.
    Cell Growth Differ; 1995 Dec 01; 6(12):1635-42. PubMed ID: 9019169
    [Abstract] [Full Text] [Related]

  • 11. Functional switching of TGF-beta1 signaling in liver cancer via epigenetic modulation of a single CpG site in TTP promoter.
    Sohn BH, Park IY, Lee JJ, Yang SJ, Jang YJ, Park KC, Kim DJ, Lee DC, Sohn HA, Kim TW, Yoo HS, Choi JY, Bae YS, Yeom YI.
    Gastroenterology; 2010 May 01; 138(5):1898-908. PubMed ID: 20038433
    [Abstract] [Full Text] [Related]

  • 12. Leptin induces proliferation and anti-apoptosis in human hepatocarcinoma cells by up-regulating cyclin D1 and down-regulating Bax via a Janus kinase 2-linked pathway.
    Chen C, Chang YC, Liu CL, Liu TP, Chang KJ, Guo IC.
    Endocr Relat Cancer; 2007 Jun 01; 14(2):513-29. PubMed ID: 17639064
    [Abstract] [Full Text] [Related]

  • 13. Sensitivity to transforming growth factor beta 1-induced growth arrest is common in human squamous cell carcinoma cell lines: c-MYC down-regulation and p21waf1 induction are important early events.
    Malliri A, Yeudall WA, Nikolic M, Crouch DH, Parkinson EK, Ozanne B.
    Cell Growth Differ; 1996 Oct 01; 7(10):1291-304. PubMed ID: 8891333
    [Abstract] [Full Text] [Related]

  • 14. Autocrine stimulatory mechanism by transforming growth factor beta in human hepatocellular carcinoma.
    Matsuzaki K, Date M, Furukawa F, Tahashi Y, Matsushita M, Sakitani K, Yamashiki N, Seki T, Saito H, Nishizawa M, Fujisawa J, Inoue K.
    Cancer Res; 2000 Mar 01; 60(5):1394-402. PubMed ID: 10728705
    [Abstract] [Full Text] [Related]

  • 15. Expression of transforming growth factor-beta1 and transforming growth factor-beta receptors in hepatocellular carcinoma and dysplastic nodules.
    Paik SY, Park YN, Kim H, Park C.
    Mod Pathol; 2003 Jan 01; 16(1):86-96. PubMed ID: 12527718
    [Abstract] [Full Text] [Related]

  • 16. Involvement of programmed cell death 4 in transforming growth factor-beta1-induced apoptosis in human hepatocellular carcinoma.
    Zhang H, Ozaki I, Mizuta T, Hamajima H, Yasutake T, Eguchi Y, Ideguchi H, Yamamoto K, Matsuhashi S.
    Oncogene; 2006 Oct 05; 25(45):6101-12. PubMed ID: 16682950
    [Abstract] [Full Text] [Related]

  • 17. p53 dephosphorylation and p21(Cip1/Waf1) translocation correlate with caspase-3 activation in TGF-beta1-induced apoptosis of HuH-7 cells.
    Fan G, Ma X, Wong PY, Rodrigues CM, Steer CJ.
    Apoptosis; 2004 Mar 05; 9(2):211-21. PubMed ID: 15004518
    [Abstract] [Full Text] [Related]

  • 18. Effect of transforming growth factor-beta1 on the cell growth and Epstein-Barr virus reactivation in EBV-infected epithelial cell lines.
    Fukuda M, Ikuta K, Yanagihara K, Tajima M, Kuratsune H, Kurata T, Sairenji T.
    Virology; 2001 Sep 15; 288(1):109-18. PubMed ID: 11543663
    [Abstract] [Full Text] [Related]

  • 19. Abrogation of transforming growth factor-beta type II receptor stimulates embryonic mouse lung branching morphogenesis in culture.
    Zhao J, Bu D, Lee M, Slavkin HC, Hall FL, Warburton D.
    Dev Biol; 1996 Nov 25; 180(1):242-57. PubMed ID: 8948588
    [Abstract] [Full Text] [Related]

  • 20. Cyclooxygenase-2 induction and transforming growth factor beta growth inhibition in rat intestinal epithelial cells.
    Sheng H, Shao J, Hooton EB, Tsujii M, DuBois RN, Beauchamp RD.
    Cell Growth Differ; 1997 Apr 25; 8(4):463-70. PubMed ID: 9101092
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.